Personalized and targeted therapy of esophageal squamous cell carcinoma: an update-Reference-Cited by-同舟云学术

Personalized and targeted therapy of esophageal squamous cell carcinoma: an update

Published:2016-07-11 Issue:1 Volume:1381 Page:66-73
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Liu Yongjing¹²³,Xiong Zhaohui³,Beasley Andrea³,D'Amico Thomas²,Chen Xiaoxin Luke³⁴

Affiliation:

1. Department of Cardiothoracic Surgery; 105th Hospital of PLA; Hefei Anhui Province China

2. Division of Thoracic Surgery; Duke University Medical Center; Durham North Carolina

3. Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute; North Carolina Central University; Durham North Carolina

4. Division of Gastroenterology and Hepatology, Department of Medicine, Center for Esophageal Disease and Swallowing; University of North Carolina at Chapel Hill; Chapel Hill North Carolina

Funder

Faculty Development Fund

National Institutes of Health

National Cancer Institute

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nyas.13144/fullpdf

Reference96 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010

2. Cancer survival in China, 2003-2005: a population-based study;Zeng;Int. J. Cancer,2014

3. Oesophageal carcinoma;Pennathur;Lancet,2013

4. Esophageal cancer;Enzinger;N. Engl. J. Med,2003

5. Multidisciplinary management of early and locally advanced esophageal cancer;Kaifi;J. Clin. Gastroenterol,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18

2. The CXCR4 might be a potential biomarker for esophageal squamous cell carcinoma: A meta-analysis;Medicine;2024-04-05

3. Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia;Redox Biology;2023-11

4. Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapy;Molecular and Clinical Oncology;2023-09-15

5. Exploring cell competition for the prevention and therapy of esophageal squamous cell carcinoma;Biochemical Pharmacology;2023-08